Haemonetics CorporationHAENYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+23.7%
5Y CAGR+33.8%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+23.7%/yr
vs +41.8%/yr prior
5Y CAGR
+33.8%/yr
Recent deceleration
Acceleration
-18.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $308.07M | +116.3% |
| 2025 | $142.45M | +23.4% |
| 2024 | $115.45M | -29.1% |
| 2023 | $162.87M | +115.0% |
| 2022 | $75.75M | +5.6% |
| 2021 | $71.77M | -34.4% |
| 2020 | $109.46M | +171.5% |
| 2019 | $40.32M | -72.3% |
| 2018 | $145.55M | +74.1% |
| 2017 | $83.60M | - |